CIK 0001196298 · Non-accelerated filer<br>Smaller reporting company
NEPHROS INC
Sign in to watch- Ticker
- NEPH
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 133971809
- Phone
- 201.343.5202
- Business address
- 380 LACKAWANNA PLACE, SOUTH ORANGE, NJ, 07079
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-05-24 | Evans Daron CEO of Specialty Renal Product | Option exercise | +1,111 | $2.70 | $3K | 9,018 |
| 2021-05-24 | Evans Daron CEO of Specialty Renal Product | Option exercise · Common Stock Warrants (Right to Buy) | −1,111 | 0 | ||
| 2021-05-24 | Evans Daron CEO of Specialty Renal Product | Option exercise · Common Stock Warrants (Right to Buy) | −1,111 | 0 | ||
| 2021-02-16 | Lobo Wesley S. Chief Marketing Officer | Grant or award | +40,557 | 40,557 | ||
| 2021-02-16 | Lobo Wesley S. Chief Marketing Officer | Grant or award · Stock Optoin (right to buy) | +114,178 | 114,178 | ||
| 2021-01-27 | WEXFORD CAPITAL LP Director | Option exercise | +3,556 | $4.59 | $16K | 94,839 |
| 2021-01-27 | WEXFORD CAPITAL LP Director | Option exercise | +2,956 | $4.14 | $12K | 97,795 |
| 2021-01-27 | WEXFORD CAPITAL LP Director | Option exercise | +3,765 | $3.60 | $14K | 101,560 |
| 2021-01-27 | WEXFORD CAPITAL LP Director | Option exercise | +4,477 | $4.50 | $20K | 106,037 |
| 2021-01-27 | WEXFORD CAPITAL LP Director | Option exercise · Stock Option (Right to Buy) | −3,556 | 3,556 | ||
| 2021-01-27 | WEXFORD CAPITAL LP Director | Option exercise · Stock Option (Right to Buy) | −2,956 | 2,956 | ||
| 2021-01-27 | WEXFORD CAPITAL LP Director | Option exercise · Stock Option (Right to Buy) | −3,765 | 3,765 | ||
| 2021-01-27 | WEXFORD CAPITAL LP Director | Option exercise · Stock Option (Right to Buy) | −4,477 | 4,477 | ||
| 2021-01-06 | WEXFORD CAPITAL LP Director | Grant or award | +3,196 | 3,196 | ||
| 2021-01-06 | Gwydir Tom Director | Grant or award | +3,666 | 6,031 | ||
| 2021-01-06 | Gwydir Tom Director | Grant or award · Stock Option (right to buy) | +6,850 | 6,850 | ||
| 2021-01-06 | Lask Alisa Director | Grant or award | +3,666 | 7,143 | ||
| 2021-01-06 | Lask Alisa Director | Grant or award · Stock Option (right to buy) | +6,850 | 6,850 | ||
| 2021-01-06 | PERSEN MALCOLM C Director | Grant or award | +5,921 | 48,774 | ||
| 2021-01-06 | PERSEN MALCOLM C Director | Grant or award · Stock Option (Right to Buy) | +6,850 | 6,850 |
Page 5 of 8 · 158 trades